Nr.NumelestudiuluiStatusLocatia/Locatiilestudiului
1Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell CancerActiv, inca nu se recruteazaOncomed SRL, Timisoara, JUD. Timis, Romania, 300239Institutul Oncologic „Prof.Dr.I.Chiricuta” Cluj-Napoca, Cluj-Napoca, Romania, 400015
2An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial CancerIn curs de recrutareBucharest, RomaniaCluj-Napoca, RomaniaCraiova, RomaniaIasi, Romania
3A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)Activ, inca nu se recruteaza„Prof. Dr. Ion Chiricuta” Oncology Institute, Cluj-Napoca, Romania, 400015S.C. Medisprof S.R.L., Cluj-Napoca, Romania, 400641″Sfantul Nectarie” Oncology Center, Craiova, Romania, 200347Oncomed SRL, Timisoara, Romania, 300239
4Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer (CheckMate901)In curs de recrutareLocal Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0191         Local Institution, Craiova, Romania, 200347, Contact: Site 0187     
5A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary TractActiv, inca nu se recruteazaOncopremium Team Srl, Baia Mare, Romania, 430291Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca; Spital de zi-Parter, Cluj-Napoca, Romania, 400015Centrul de Oncologie Sfantul Nectarie, Craiova, Romania, 200347Centrul de Radioterapie AMETHYST, Floresti, Romania, 407280Oncomed SRL; Oncologie, Timisoara, Romania, 300239
6An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer (CheckMate 274)Activ, inca nu se recruteazaLocal Institution, Bucuresti, Romania, 021389Local Institution, Craiova, Romania, 200347Local Institution, Floresti, Romania, 407280Local Institution, Timisoara, Timis, Romania, 300239
7A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBCIn curs de recrutareInstitute Of Oncology „Prof.Dr.Alexandru Trestioreanu” Bucharest, Bucharest, Romania, 020122, Contact: Aurelia Alexandru, Site 0058         Local Institution, Craiova, Romania, 200347, Contact: Site 0076
8A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice (IMreal)In curs de recrutareCounty Hospital Alba; Oncology, Alba Iulia, Romania, 510073Centrul Medical Focus; Oncologie medicala, Bucharest, Romania, 021389University Clinical Emergency Hospital Bucharest, Bucharest, RomaniaInstitutul Oncologic Prof. Dr. Al. Trestioreanu Bucuresti, Bucuresti, Romania, 022328Sanador Medical Center; Medical Oncology, Bucuresti, RomaniaSpitalul Clinic Judetean de Urgenta Sf. Apostol Andrei Constanta, Constanta, Romania, 900591Institutul Regional de Oncologie Iasi, Iasi, Romania, 700483Spitalul Municipal Ploiesti, Ploiesti, Romania, 100337Oncomed SRL; Oncologie, Timisoara, Romania, 300239Oncocenter Timisoara , Timişoara, Romania, 300166
9A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer (RANGE)Activ, inca nu se recruteazaFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon – Fri from 9 AM to 5 PM Eastern Time (UTC/GMT – 5 hours, EST), or speak with your personal physician.      Baia Mare, Romania, 430110Cluj-Napoca, Romania, 400058Craiova, Romania, 200347
10A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney (CheckMate 914)In curs de recrutareLocal Institution, Bucharest, Romania, 50659, Contact: Site 0201         Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0200         Local Institution, Craiova, Romania, 200347, Contact: Site 0199         Local Institution, Lasi, Romania, 700483, Contact: Site 0202     
11An Immunotherapy Study of Nivolumab Plus Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney CancerActiv, inca nu se recruteazaLocal Institution, Bucharest, Romania, 014142, Contact: Site 0076         Local Institution, Bucharest, Romania, 020122, Contact: Site 0061         Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0056         Local Institution, Constanta, Romania, 900591, Contact: Site 0059         Local Institution, Craiova, Romania, 200347, Contact: Site 0065 
12Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma (IMvigor130)Activ, inca nu se recruteazaSpitalul Judetean de Urgenta Dr Constantin Opris, Baia Mare, Romania, 430031Institute Of Oncology Bucharest; Medical Oncology, Bucharest, Romania, 022338Oncology Center Sf. Nectarie, Craiova, Romania, 200347
13Trial to Assess Safety and Efficacy of Lenvatinib in Combination With Everolimus in Participants With Renal Cell CarcinomaActiv, inca nu se recruteazaMedisprof SRL, Cluj-Napoca, RomaniaProf Dr I Chiricuta Institute of Oncology, Cluj-Napoca, RomaniaOncology Center Sfantul Nectarie, Craiova, RomaniaOncocenter Clinical Oncology, Timisoara, Romania
14A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 9ER)Activ, inca nu se recruteazaInstit. Prof.Dr.Ion Chiricuta, Cluj-Napoca, Romania, 400015Sf. Nectarie Oncology Center, Craiova, Romania, 200347
15A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)In curs de recrutareCentrul de Oncologie Sfantul Nectarie, Craiova, Dolj, Romania, 200347Oncolab SRL, Craiova, Dolj, Romania, 200385Medisprof SRL , Cluj-Napoca, Romania, 400461Clinical Emergency Hospital of Constanta, Constanta, Romania, 900591Center of Oncology Euroclinic, Iasi, Romania, 700106Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu, Romania, 550245Oncocenter – Oncologie Clinica SRL, Timisoara, Romania, 300166
16Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)In curs de recrutareSpitalul Clinic Judetean de Urgenta ‘Sf Apostol Andrei’ Constanta Not yet recruiting Constanta, Romania, 900591
17A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney CancerActiv, nu se recruteazaLocal Institution Bucharest, Romania, 020122 Local Institution Cluj-Napoca, Romania, 400015 Local Institution Constanta, Romania, 900591 Local Institution Craiova, Romania, 200347
18Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)Activ, nu se recruteazaLocal Institution Bucharest, Romania, 022328 Local Institution Craiova, Romania, 200385 Local Institution Iasi, Romania, 700106 Local Institution Timisoara, Romania, 300167
19A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (CheckMate 7G8)In curs de recrutareLocal Institution Not yet recruiting Bucharest, Romania, 022328 Contact: Site 0039          Local Institution Not yet recruiting Cluj-Napoca, Romania, 400015 Contact: Site 0014          Local Institution Not yet recruiting Craiova, Romania, 200347 Contact: Site 0013         
20Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)In curs de recrutareS.C. Radiotherapy Center Cluj S.R.L ( Site 0252) Recruiting Cluj-Napoca, Cluj, Romania, 407280 Contact: Study Coordinator    +40742206212       S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0248) Recruiting Craiova, Dolj, Romania, 200347 Contact: Study Coordinator    +40722161545      

(Visited 8 times, 1 visits today)